शेयर बाजार समाचार
नवीनतम वित्तीय समाचार · अपडेट किया जुल 22, 2026
यूनाइटेडहेल्थ ग्रुप के शेयर बर्कशायर हैथवे द्वारा स्वास्थ्य बीमा कंपनी में हिस्सेदारी बेचने के बाद गिरे
UnitedHealth Group stock slides after Berkshire Hathaway exits position in the health insurer
The panelists generally agree that Berkshire Hathaway's sale of its entire UnitedHealth stake is likely a portfolio rebalancing move rather …
साप्ताहिक स्टॉक सूची
Weekly Stock List
The panel consensus is that Argus' Focus List lacks sufficient data for investors to make informed decisions, with high turnover …
Kioxia AI मेमोरी चिप बूम के बीच अमेरिकी ADS लिस्टिंग की योजना बना रहा है
Kioxia plans U.S. ADS listing amid AI memory chip boom
Panelists are divided on Kioxia's U.S. ADS listing and Q2 guidance. While some see it as a 'sell the news' …
रेयोनियर (RYN) एक इन्फ्लेशन हेज निवेश क्यों है?
What Makes Rayonier (RYN) an Inflation Hedge Investment?
The panelists generally agree that the RYN-PotlatchDeltic merger creates a larger timberland REIT with potential for asset sales and buybacks, …
यहाँ CNH इंडस्ट्रियल N.V. (CNH) Q1 में क्यों बढ़ा
Here’s Why CNH Industrial N.V. (CNH) Surged in Q1
The panel's net takeaway is that CNH Industrial's stock is at risk due to persistent margin pressure, structural pricing power …
$4,500 प्रति औंस पर सोना रोजमर्रा के अमेरिकियों को फावड़े उठाने पर मजबूर कर रहा है — और कुछ दसियों हज़ार कमा रहे हैं
Gold at $4,500 an ounce has everyday Americans grabbing shovels — and some are making tens of thousands
The panel consensus is that the romanticization of amateur gold prospecting is a distraction from the real market drivers of …
NextEra Energy Dominion का अधिग्रहण $66.8 बिलियन के सौदे में करेगी
NextEra Energy to acquire Dominion in $66.8 billion deal
The panel is divided on the $66.8 billion merger between NEE and D, with concerns about regulatory risks, integration challenges, …
NRx Pharmaceuticals Q1 आयर्निंग्स कॉल हाइलाइट्स
NRx Pharmaceuticals Q1 Earnings Call Highlights
NRx's progress on KETAFREE and NRX-100 is encouraging, but the company faces significant financial and operational challenges, including high cash …
इम्यूनोम (IMNM) एक सम्मोहक निवेश अवसर क्या प्रदान करता है?
What Offers Immunome (IMNM) a Compelling Investment Opportunity?
The panel's discussion on Immunome (IMNM) highlights high execution risk, with a narrow focus on Varegacestat's success in a small, …
क्या लेगेसी एजुकेशन (LGCY) हेल्थकेयर एजुकेशन में एक विजेता के रूप में उभर रहा है?
Is Legacy Education (LGCY) Emerging as a Winner in Healthcare Education?
The panel consensus is bearish on LGCY, citing lack of revenue and enrollment data, regulatory risks, and thin institutional sponsorship.
न्यूरोएक्सिस (NRXS) प्रतिपूर्ति और दिशानिर्देश की गति पर चढ़ता है
NeurAxis (NRXS) Climbs on Reimbursement and Guideline Momentum
The panel consensus is bearish on NeurAxis (NRXS), citing extreme illiquidity, high execution risk, and uncertainty around reimbursement translating into …
दबाव में: G7 सरकारी ऋण में दर्द को ट्रैक करना
Under pressure: Tracking the pain in G7 government debt
The panel agrees that high debt-to-GDP ratios and rising yields pose significant risks, with the key concern being the potential …